Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

NCT00074269 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped Terminated early due to poor enrollment

Conditions

Breast Cancer

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: filgrastim
BIOLOGICAL: graft-versus-tumor induction therapy
BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: cyclosporine
DRUG: fludarabine phosphate
DRUG: melphalan
DRUG: methotrexate
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

University of California, San Diego

Collaborators

[object Object]